Sort
16,300 grants matching “fatty liver disease”
Pathophysiology of Type 2 Diabetes in Youth
$408,750Yale University · R01 · FY2005 · HD
Measuring Lipid Flux By Ultra High Resolution Mass Spectrometry
$408,750Matthew Alvin Mitsche · Ut Southwestern Medical Center · R35 · FY2020 · GM
R-spondin1-LGR4 Signaling and Ischemia/Reperfusion Injury in Steatotic Liver
$408,747Michael W. Mulholland · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Molecular Regulation of Apoprotein B Degradation
$408,678Edward A Fisher · New York University School Of Medicine · R01 · FY2017 · HL
Molecular Regulation of Apoprotein B Degradation
$408,678Edward A Fisher · New York University School Of Medicine · R01 · FY2019 · HL
Molecular Regulation of Apoprotein B Degradation
$408,678Edward A Fisher · New York University School Of Medicine · R01 · FY2018 · HL
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease
$408,636Irina A. Kirpich · University Of Louisville · R01 · FY2025 · AA
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Molecular Regulation of Apoprotein B Degradation
$408,570Edward A Fisher · New York University School Of Medicine · R01 · FY2010 · HL
Molecular Regulation of Apoprotein B Degradation
$408,570Edward A Fisher · New York University School Of Medicine · R01 · FY2011 · HL
A New Molecular Mechanism to Bioengineering a Liver
$408,538Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Soluble epoxide hydrolase: assessment of in vivo activity and regulation by gut microbiota
$408,530Jang H. Youn · University Of Southern California · R01 · FY2022 · HL
Soluble epoxide hydrolase: assessment of in vivo activity and regulation by gut microbiota
$408,510Jang H. Youn · University Of Southern California · R01 · FY2023 · HL
Mechanistic Connection between Interorganellar Communication and Obesity-associated Diseases
$408,459Xing Zeng · Ut Southwestern Medical Center · R01 · FY2024 · DK
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$408,425Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
Novel Liver Signaling Pathways Controlling Adiposity
$408,414Terry D Hinds · University Of Kentucky · R01 · FY2021 · DK
Waters Xevo TQ-XS system
$408,398Pawel K Lorkiewicz · University Of Louisville · S10 · FY2022 · OD
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
$408,360Rajan Sah · Washington University · R01 · FY2022 · DK
Role of HDAC6 in the Regulation of Energy Homeostasis and Leptin Sensitivity
$408,338Roger D Cone · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Cyclin D1/CDK4 Complex in Hepatocyte Proliferation
$408,309Jeffrey H Albrecht · Hennepin Healthcare Research Institute · R01 · FY2014 · DK
Myeloid FoxO1 in Lipid Metabolism
$408,222Hengjiang Henry Dong · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Role of NgBR in Hepatic Steatosis
$408,222Qing Miao · Nyu Long Island School Of Medicine · R01 · FY2021 · DK